FDA·Medicines·November 4, 2026

MSN Laboratories recalls Atorvastatin Calcium Tablets, USP, 40mg over foreign tablets or capsules

The notice says the 1,000-count bottles of atorvastatin calcium tablets may contain foreign tablets or capsules, and 13,296 bottles were distributed nationwide in the USA.

What to do

The notice does not give instructions. Read the official notice for details.

Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.

Recall details

Product
Atorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL Laboratories Private Limited, Telangana - 509228, India; Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854-3714. NDC: 72205-024-99
Hazard
Presence of Foreign Tablets/Capsules
Units
13,296 1,000-count bottles
Where sold
Nationwide in the USA.
FDA classification
Class II · Ongoing
Classified by FDA
October 29, 2026
Recall started
October 21, 2026
FDA enforcement report
November 4, 2026
Identifiers
  • Codes: Lot: DRF09618A, Exp 08-31-2029, DRG02110A, Exp 01-31-2030.
  • FDA recall number: D-0113-2027

The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.

Official notice

The notice's own wording from FDA.

Product
Atorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL Laboratories Private Limited, Telangana - 509228, India; Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854-3714. NDC: 72205-024-99
Reason for recall
Presence of Foreign Tablets/Capsules
Classification
Class II (Ongoing)
Distribution
Nationwide in the USA.
Quantity
13,296 1,000-count bottles

Related recalls